We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$20.1B
AUM Growth
+$2.3B
Cap. Flow
+$1.49B
Cap. Flow %
7.41%
Top 10 Hldgs %
47.53%
Holding
3,401
New
1,240
Increased
482
Reduced
600
Closed
1,059

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$331M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$276M
3
AMZN icon
Amazon
AMZN
+$197M
4
XOM icon
ExxonMobil
XOM
+$162M
5
V icon
Visa
V
+$161M

Sector Composition

Rank Sector Weight
1 Technology 10.97%
2 Financials 6.47%
3 Healthcare 6.17%
4 Communication Services 5.95%
5 Industrials 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XNTK icon
1351
CALL
State Street SPDR NYSE Technology ETF
XNTK
$2.23B
$809K ﹤0.01%
14,300
+10,200
+249% +$1.93M
FLGV icon
1352
Franklin US Treasury Bond ETF
FLGV
$1.04B
$808K ﹤0.01%
+38,405
New +$799K
NVDQ icon
1353
T-Rex 2X Inverse NVIDIA Daily Target ETF
NVDQ
$16.9M
$807K ﹤0.01%
+8,648
New +$991K
PRVA icon
1354
Privia Health
PRVA
$2.87B
$807K ﹤0.01%
44,348
+19,804
+81% +$378K
CTS icon
1355
CTS Corp
CTS
$1.89B
$806K ﹤0.01%
+16,663
New +$809K
DHC
1356
Diversified Healthcare Trust
DHC
$2.14B
$806K ﹤0.01%
192,457
-36,282
-16% -$122K
LADR
1357
Ladder Capital
LADR
$1.24B
$806K ﹤0.01%
+69,510
New +$824K
ACAD icon
1358
Acadia Pharmaceuticals
ACAD
$5.03B
$805K ﹤0.01%
52,368
-123,451
-70% -$2.06M
PRO
1359
DELISTED
PROS Holdings
PRO
$803K ﹤0.01%
+43,401
New +$917K
OPK icon
1360
Opko Health
OPK
$1.02B
$801K ﹤0.01%
538,063
+206,065
+62% +$306K
BUD icon
1361
AB InBev
BUD
$165B
$800K ﹤0.01%
+12,070
New +$744K
QCOM icon
1362
PUT
Qualcomm
QCOM
$176B
$799K ﹤0.01%
+4,700
New +$830K
VSH icon
1363
Vishay Intertechnology
VSH
$5.43B
$799K ﹤0.01%
+42,302
New +$881K
BMY icon
1364
Bristol-Myers Squibb
BMY
$132B
$798K ﹤0.01%
+15,432
New +$724K
FBMS
1365
DELISTED
The First Bancshares, Inc.
FBMS
$793K ﹤0.01%
+24,694
New +$764K
SCHV
1366
Schwab US Large-Cap Value ETF
SCHV
$16.1B
$788K ﹤0.01%
+29,448
New +$756K
SLB icon
1367
CALL
SLB Ltd
SLB
$75B
$788K ﹤0.01%
+18,800
New +$837K
LYEL icon
1368
Lyell Immunopharma
LYEL
$360M
$785K ﹤0.01%
+28,451
New +$836K
EXLS icon
1369
EXL Service
EXLS
$5.29B
$783K ﹤0.01%
20,545
-128,421
-86% -$4.49M
CSCO icon
1370
PUT
Cisco
CSCO
$479B
$782K ﹤0.01%
14,700
+3,000
+26% +$146K
GHC icon
1371
Graham Holdings Company
GHC
$5.02B
$780K ﹤0.01%
950
-2,905
-75% -$2.21M
RUN icon
1372
Sunrun
RUN
$2.46B
$780K ﹤0.01%
+43,212
New +$768K
EB
1373
DELISTED
Eventbrite
EB
$778K ﹤0.01%
285,174
+111,354
+64% +$424K
TRMK icon
1374
Trustmark
TRMK
$2.75B
$777K ﹤0.01%
+24,432
New +$786K
UBSI icon
1375
United Bankshares
UBSI
$6.62B
$777K ﹤0.01%
+20,955
New +$765K

Similar funds

HRT Financial's Q3 2024 Portfolio in Review

As of Q3 2024, HRT Financial held 3,401 positions worth $20.1B, up 13% from $17.8B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

HRT Financial deployed $1.49B of net new capital in Q3 2024, opening 1,240 new positions and adding to 482 existing holdings. Its largest new stake was Microsoft: 1,252,432 shares worth $539M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.3% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $276M trimmed.

  • HRT Financial's largest Q3 2024 buy was Microsoft: 1,252,432 shares worth $539M.
  • HRT Financial added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $516M increase.
  • HRT Financial's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $276M.
  • HRT Financial fully exited Apple in Q3 2024, selling an estimated $331M.
  • HRT Financial's ten largest holdings make up 48% of its $20.1B portfolio in Q3 2024.
  • HRT Financial opened 1,240 new positions and closed 1,059 in Q3 2024.
  • HRT Financial's portfolio value rose 13% quarter-over-quarter to $20.1B.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.